| 14706-6 |
Doxepin |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Doxepin [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14706-6 |
|
|
|
|
Both |
|
|
|
0 |
Doxepin Ur-sCnc |
|
|
|
Y |
|
Adapin; Aponal; Dox; Doxpin; DRUG/TOXICOLOGY; Drugs; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Sinequan; Substance concentration; UA; UR; Urn |
2.42 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 14707-4 |
Doxepin+Nordoxepin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Doxepin+Nordoxepin [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14707-4 |
|
|
|
|
Both |
|
|
|
0 |
Doxepin+Nor SerPl-sCnc |
|
|
|
Y |
|
Adapin; Aponal; Desdoxepin; Desdoxepine; Desmeth; Desmethyl; Desmethyldox; Desmethyldoxepin; Dox; Doxepin metabolite; Doxpin; DRUG/TOXICOLOGY; Drugs; Level; N-desmethyldoxepin; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; Sinequan; SR; Substance concentration |
2.34 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 14708-2 |
Endomysium Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Endomysium Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
SERO |
|
14708-2 |
|
|
|
|
Both |
|
|
|
0 |
Endomysium Ab Titr Ser |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); EMA; Endomysial; Gastro; Gastroenterology; GI; Point in time; Random; Serology; Serum; SmQn; SR; Titer; Titered; Titre; Transglutaminase; Ttr; UniversalLabOrders |
2.75 |
1.0k |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
| 14709-0 |
Eosinophils/Leukocytes |
NFr |
Bronchial |
Pt |
Qn |
Manual count |
|
ACTIVE |
Eosinophils/Leukocytes in Bronchial specimen by Manual count |
|
NAM |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
14709-0 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
Eosinophil NFr Bronch Manual |
|
|
|
Y |
|
Bro; Eos; Eosin; Eosino; Eosinophil; Eosins; HEMATOLOGY/CELL COUNTS; Leuc; Leuk; Leukocyte; Lkcs; Manl; Number fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; WBC; WBCs; White blood cell; White blood cells |
2.79 |
1.0k |
|
|
|
|
|
|
|
% |
|
|
Release 2.79: COMPONENT: Triggered by Coll w SCT: This is a specific fraction case where the denominator is percentage or /100. Because the logic is that the percentage piece is captured by Property: NFr (Numeric Fraction), and by Unit: %, therefore, it is redundant to include "100" in the component; |
0 |
| 1471-2 |
Follitropin^1H post dose gonadotropin releasing hormone |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Follitropin [Mass/volume] in Serum or Plasma --1 hour post dose gonadotropin releasing hormone |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
1471-2 |
|
|
|
|
Observation |
|
|
|
0 |
FSH 1h p GnRH SerPl-mCnc |
|
|
|
Y |
|
1 hour; 1.0Hr; 1h p GnRH; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; GHR; GnRH; Horm; Level; LHRH; Luliberin; Luteinizing hormone releasing hormone; Lutropin release factor; Mass concentration; p dose; p GnRH; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 14710-8 |
Ephedrine+Pseudoephedrine |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
ePHEDrine+Pseudoephedrine [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
14710-8 |
|
|
|
|
Both |
|
|
|
0 |
Ephedrin+Pseudo Gast Ql |
|
|
|
|
|
Cenafed; DRUG/TOXICOLOGY; Drugs; Ectasule; Ephedrin+Pseudo; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; Pseudoephed; QL; Qual; Qualitative; Random; Screen; Sudafed |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14711-6 |
EPINEPHrine |
SCnc |
Plas |
Pt |
Qn |
|
|
ACTIVE |
EPINEPHrine [Moles/volume] in Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14711-6 |
|
|
|
|
Both |
|
|
|
0 |
Epineph Plas-sCnc |
|
|
|
Y |
|
Adrenalin; Adrenaline; Adreneline; Chemistry; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration |
2.34 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 14712-4 |
EPINEPHrine |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
EPINEPHrine [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/24 H |
|
|
|
|
|
|
CHEM |
|
14712-4 |
|
|
|
|
Both |
|
|
|
0 |
Epineph 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Adrenalin; Adrenaline; Adreneline; Chemistry; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.73 |
1.0k |
|
|
|
|
|
|
|
nmol/(24.h) |
|
|
|
0 |
| 14713-2 |
Erythrocytes |
NCnc |
Pericard fld |
Pt |
Qn |
Manual count |
|
ACTIVE |
Erythrocytes [#/volume] in Pericardial fluid by Manual count |
|
MIN |
DefinitionDescription |
|
|
10*6/L |
|
|
|
|
|
|
HEM/BC |
|
14713-2 |
|
Manual count |
|
|
Observation |
|
|
|
0 |
RBC # Pcar Manual |
|
|
|
Y |
|
#; ABS; absolute; absolutes; Cardio; Cardiology; Cnt; Count; Count/volume; CT; Discocytes; Erthrocyte; Erythrocyte; Heart Disease; HEMATOLOGY/CELL COUNTS; Manl; Number concentration; Number Concentration (count/vol); Pcar; Pericardial fluid; Point in time; QNT; Quan; Quant; Quantitative; Random; RBC; RBCS; Red blood cell; Red blood cells; Red blood corpuscle; Red blood corpusles; Red cell; Red cells |
2.73 |
1.0k |
|
|
|
|
|
|
|
/uL |
|
|
|
0 |
| 14714-0 |
Erythropoietin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Erythropoietin (EPO) [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
14714-0 |
|
|
|
|
Both |
|
|
|
0 |
EPO SerPl-sCnc |
|
|
|
Y |
|
Chemistry; EPO; Epoetin; Erthropoyetin; Erythropoetin; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 14715-7 |
Estradiol |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Estradiol (E2) [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHEM |
|
14715-7 |
|
|
|
|
Both |
|
|
|
0 |
Estradiol SerPl-sCnc |
|
|
|
Y |
|
17-beta estradiol; Chemistry; E2; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Oestradiol; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 14716-5 |
Estriol |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Estriol (E3) [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14716-5 |
|
|
|
|
Both |
|
|
|
0 |
Estriol SerPl-sCnc |
|
|
|
Y |
|
Chemistry; E3; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 14717-3 |
Estriol |
SCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Estriol (E3) [Moles/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
CHEM |
|
14717-3 |
|
|
|
|
Both |
|
|
|
0 |
Estriol Ur-sCnc |
|
|
|
Y |
|
Chemistry; E3; Gyn; Gynecology; Level; OB; ObGyn; Obstetrics; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn |
2.34 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
| 14718-1 |
Estriol |
SRat |
Urine |
24H |
Qn |
|
|
ACTIVE |
Estriol (E3) [Moles/time] in 24 hour Urine |
|
MIN |
DefinitionDescription |
|
|
nmol/24 H |
|
|
|
|
|
|
CHEM |
|
14718-1 |
|
|
|
|
Both |
|
|
|
0 |
Estriol 24h Ur-sRate |
|
|
|
Y |
|
1 day; 24 hours; 24HR; Chemistry; E3; Gyn; Gynecology; OB; ObGyn; Obstetrics; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn |
2.42 |
1.0k |
|
|
|
|
|
|
|
nmol/(24.h) |
|
|
|
0 |
| 14719-9 |
Ethanol |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Ethanol [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14719-9 |
|
|
|
|
Both |
|
|
|
0 |
Ethanol SerPl-sCnc |
|
|
|
Y |
|
Alc; Alcohol; DRUG/TOXICOLOGY; Drugs; Ethyl alcohol; EtOH; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 1472-0 |
Follitropin^2H post 100 ug luteinizing releasing hormone IV |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
DISCOURAGED |
Follitropin [Mass/volume] in Serum or Plasma --2 hours post 100 ug luteinizing releasing hormone IV |
|
NAM |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
CHAL |
|
1472-0 |
|
|
|
|
Observation |
|
|
|
0 |
FSH 2h p 100 ug LRH IV SerPl-mCnc |
|
|
|
Y |
|
120 min; 120 minutes; 120min; 2 hours; 2h p 100 ug LRH IV; After; CHEMISTRY.CHALLENGE TESTING; Follicle stimulating hormone; FSH; Horm; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.69 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
| 14720-7 |
Ethosuximide |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Ethosuximide [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14720-7 |
|
|
|
|
Both |
|
|
|
0 |
Ethosuximide SerPl-sCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Zarontin |
2.34 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 14721-5 |
Ethylene glycol |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Ethylene glycol [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14721-5 |
|
|
|
|
Both |
|
|
|
0 |
Ethylene Glycol SerPl-sCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 14722-3 |
Extractable nuclear Ab |
PrThr |
Ser |
Pt |
Ord |
|
|
ACTIVE |
Extractable nuclear Ab [Presence] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SERO |
|
14722-3 |
|
|
|
|
Both |
|
|
|
0 |
ENA Ab Ser Ql |
|
|
|
|
|
ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; ENA; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology; Serum; SR |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14723-1 |
Ferritin |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Ferritin [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
pmol/L |
|
|
|
|
|
|
CHEM |
|
14723-1 |
|
|
|
|
Both |
|
|
|
0 |
Ferritin SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Ferr; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
pmol/L |
|
|
|
0 |
| 14724-9 |
Ferritin |
Imp |
Bld |
Pt |
Nom |
|
|
ACTIVE |
Ferritin [Interpretation] in Blood |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
14724-9 |
|
|
|
|
Observation |
|
|
|
0 |
Ferritin Bld-Imp |
|
|
|
|
|
Blood; Chemistry; Ferr; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Point in time; Random; WB; Whole blood |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 14725-6 |
Fluid |
Type |
Body fld |
Pt |
Nom |
|
|
ACTIVE |
[Type] of Body fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SPEC |
|
14725-6 |
|
|
|
|
Observation |
|
|
|
0 |
Body fld type |
|
|
|
|
|
B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; Nominal; Point in time; Random; SPEC; Typ |
2.73 |
1.0k |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 14726-4 |
Fluoride |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Fluoride [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14726-4 |
|
|
|
|
Both |
|
|
|
0 |
Fluoride SerPl-sCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Fl; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0k |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
| 14727-2 |
FLUoxetine |
PrThr |
Gast fld |
Pt |
Ord |
|
|
ACTIVE |
FLUoxetine [Presence] in Gastric fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
14727-2 |
|
|
|
|
Both |
|
|
|
0 |
FLUoxetine Gast Ql |
|
|
|
|
|
DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; Prozac; QL; Qual; Qualitative; Random; Screen |
2.56 |
1.0k |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 14728-0 |
FLUoxetine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
FLUoxetine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
nmol/L |
|
|
|
|
|
|
DRUG/TOX |
|
14728-0 |
|
|
|
|
Both |
|
|
|
0 |
FLUoxetine SerPl-sCnc |
|
|
|
Y |
|
DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; Prozac; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.34 |
1.0k |
|
|
|
|
|
|
|
nmol/L |
|
|
|
0 |
